These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20948775)

  • 1. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
    Schubert I; Köster I; Lehmkuhl G
    Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence (letter to the editor): Uncritical prescription.
    Neraal T
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):919; author reply 919-20. PubMed ID: 21249142
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
    Garbe E; Mikolajczyk RT; Banaschewski T; Petermann U; Petermann F; Kraut AA; Langner I
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):452-8. PubMed ID: 23234588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy.
    Sluiter MN; de Vries YA; Koning LG; Hak E; Bos JHJ; Schuiling-Veninga CCM; Batstra L; Doornenbal JM; de Jonge P
    Adm Policy Ment Health; 2020 Mar; 47(2):291-299. PubMed ID: 31620909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence (letter to the editor): What about the dam break upstream?
    Börner J
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):918-9. PubMed ID: 21249140
    [No Abstract]   [Full Text] [Related]  

  • 7. Correspondence (letter to the editor): Is the treatment the problem?
    Dietrich K
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):918. PubMed ID: 21249139
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions].
    Schmidt-Troschke SO; Ostermann T; Melcher D; Schuster R; Erben CM; Matthiessen PF
    Gesundheitswesen; 2004 Jun; 66(6):387-92. PubMed ID: 15206042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of methylphenidate to children and youth, 1990-1996.
    Miller AR; Lalonde CE; McGrail KM; Armstrong RW
    CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.
    Song I; Shin JY
    Epidemiol Health; 2016; 38():e2016045. PubMed ID: 27866408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Explanations for Increasing Methylphenidate Use in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany From 2004 to 2013.
    Langner I; Haug U; Scholle O; Lindemann C; Schröder C; Riedel O
    J Clin Psychopharmacol; 2019; 39(1):39-45. PubMed ID: 30489381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
    McCarthy S; Wilton L; Murray ML; Hodgkins P; Asherson P; Wong IC
    BMC Pediatr; 2012 Jun; 12():78. PubMed ID: 22712630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
    Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
    Dalsgaard S; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
    Grimmsmann T; Himmel W
    Eur J Clin Pharmacol; 2021 Jan; 77(1):107-115. PubMed ID: 32803292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of methylphenidate among children in Iceland 1989-2006].
    Zoëga H; Baldursson G; Halldórsson M
    Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.
    Fogelman Y; Vinker S; Guy N; Kahan E
    CNS Drugs; 2003; 17(12):915-9. PubMed ID: 12962530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.